Market news

BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contrast with OPCH's slower growth and chronic-therapy pressures.

BrightSpring Health Services (NASDAQ:BTSG) outlined its growth strategy across pharmacy and provider services at the Bernstein healthcare services conference, emphasizing specialty pharmacy expansion, home health acquisitions, technology investments and opportunities to integrate services for comple

BrightSpring Health Services (BTSG) is back on investor radar after Carillon Eagle Small Cap Growth Fund highlighted the healthcare provider in its second quarter 2026 letter, citing revenue and adjusted EBITDA ahead of IPO expectations. Despite the upbeat fund commentary, BrightSpring Health Services has hit a softer patch on the screen, with the share price at US$56.55 after a 1-day share price return of 1.24% but a 90-day share price return that has declined 16.36%. The year-to-date share...

Momentum stocks Centene, BrightSpring Health Services and Delek US show strong annual gains despite recent weekly pullbacks.

Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. The letter can be downloaded here. Small-cap stocks rallied broadly in the second quarter, with the Russell 2000 Growth Index (+25.71%) outpacing Value +17.24%). Information Technology (+46.79%) led all sectors, supported by solid gains […]

BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.

Detailed price information for Comfort Systems USA (FIX-N) from The Globe and Mail including charting and trades.

BrightSpring Health Services (BTSG) is back in focus after recent reports highlighted strong quarterly performance, long term revenue growth and an approximately 9% uplift in earnings expectations that coincided with a Zacks Rank #1 rating. The share price tells a similar story of strong interest in BrightSpring Health Services, with a year-to-date share price return of 58.59% and a 1-year total shareholder return of 156.64%. This comes even after a 15.95% decline over the past 30 days from...

Detailed price information for Celestica Inc (CLS-N) from The Globe and Mail including charting and trades.

CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including BrightSpring Health Services (NASDAQ:BTSG) and its peers.

BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.

BrightSpring Health Services (BTSG) was in focus after releasing second quarter 2026 results on July 31, alongside updated full year revenue guidance that shaped investor expectations for the rest of the year. See our latest analysis for BrightSpring Health Services. BrightSpring Health Services shares have been volatile in recent weeks, with a 3.09% 1 day share price gain following earnings offset by a 14.30% decline over 30 days. However, the year to date share price return of 55.42% and 1...

BrightSpring Health Services stock has delivered a very strong 166.5% gain over the past year, yet recent pullbacks and a mixed valuation score leave investors weighing how much of the good news is already reflected in the price. Over the last 12 months the share price is up 166.5%, which signals that expectations for BrightSpring Health Services are already running high. Stronger revenue momentum and growth in pharmacy and care services can support a premium, while concerns around profit...

BTSG's specialty, infusion and home health momentum support growth, while IRA pressure and customer exits may weigh on near-term margins.

BrightSpring Health is rated a Hold with a greater margin of safety, M&A execution, and reimbursement policy risks. Read more on BTSG stock here.

Detailed price information for Synchrony Financial (SYF-N) from The Globe and Mail including charting and trades.

Detailed price information for Brookdale Senior Living Inc (BKD-N) from The Globe and Mail including charting and trades.

Detailed price information for Brightspring Health Services Inc (BTSG-Q) from The Globe and Mail including charting and trades.

Detailed price information for Brightspring Health Services Inc (BTSG-Q) from The Globe and Mail including charting and trades.

BrightSpring's 18.1% weekly slide clashes with strong growth and raised guidance as valuation, policy and integration risks test the rebound case.

Detailed price information for Wave Life Sciences Inc (WVE-Q) from The Globe and Mail including charting and trades.

In the second quarter of 2026, BrightSpring Health Services reported revenue of US$3.87 billion and net income of US$84.29 million, with earnings per share rising sharply versus a year earlier and six‑month results also materially higher. Alongside these results, the company raised its full‑year 2026 revenue guidance to a range of US$15.10 billion to US$15.43 billion, highlighting management confidence even as investors weigh what this means for profit margins and growth expectations. With...

BTSG's Q2 earnings and revenues beat estimates as pharmacy and provider growth drive margin gains and a higher 2026 outlook.

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday after market hours. Here’s what you need to know.

Moby summary of BrightSpring Health Services, Inc. Common Stock's Q2 2026 earnings call

Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) fell 17.5% in the afternoon session after the company reported strong second-quarter results and increased its full-year guidance, prompting a "sell-the-news" reaction from investors.

BrightSpring Health Services Inc (BTSG) raises full-year 2026 guidance on strong Pharmacy Solutions and Provider Services growth, despite IRA headwinds.

Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 23% year on year to $3.87 billion. The company’s full-year revenue guidance of $15.26 billion at the midpoint came in 1.3% above analysts’ estimates. Its non-GAAP profit of $0.45 per share was 13% above analysts’ consensus estimates.

While the top- and bottom-line numbers for BrightSpring Health Services, Inc. (BTSG) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of +21.62% and +6.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2026, and increased full year 2026 Revenue and Adjusted EBITDA1 guidance. Second Quarter 2026 Financial Highlights(note: On March 30, 2026, BrightSpring completed the divestiture of the Community Living b

BrightSpring Health Services (NASDAQ:BTSG) reported second-quarter 2026 results that exceeded its baseline expectations, led by growth in its Pharmacy Solutions and Provider Services businesses, while reaffirming confidence in its updated full-year outlook. Chief Executive Officer Jon Rousseau said

BTSG stock plunged 18% after Q2 earnings. See BrightSpring’s EPS/revenue beat, raised 2026 guidance, valuation concerns and key metrics—read now.

Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) will be reporting results this Friday morning. Here’s what you need to know.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Detailed price information for Permian Resources Corp (PR-N) from The Globe and Mail including charting and trades.

S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS) in the S&P MidCap 400, and Karman Holdings Inc. (NYSE: KRMN) will replace BrightSpring Health Services in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 17. S&P 500 constituent Baker Hughes Co. (NASD: BKR) is to acquire Chart Industries in a deal expected to close July 16, pending final closing conditions.